Neurochemical, behavioral, and physiological effects of pharmacologically enhanced serotonin levels in serotonin transporter (SERT)-deficient mice

Psychopharmacology

Volumn 201, Issue 2, 2008, Pages 203-218

  Fox, Meredith A ^a   Jensen, Catherine L ^a   French, Helen T ^a   Stein, Alison R ^a   Huang, Su Jan ^a   Tolliver, Teresa J ^a   Murphy, Dennis L ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

5 hydroxy L tryptophan (5 HTP); 8 hydroxy 2 (di n propylamino)tetralin (8 OH DPAT); Dopamine transporter (DAT); High performance liquid chromatography (HPLC); Serotonin syndrome behaviors; Temperature

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; 3,4 DIHYDROXYPHENYLACETIC ACID; 5 CARBAMOYLTRYPTAMINE; 5 HYDROXYINDOLEACETIC ACID; 5 HYDROXYTRYPTOPHAN; CATECHOLAMINE; CLORGYLINE; DOPAMINE; DOPAMINE TRANSPORTER; MONOAMINE OXIDASE INHIBITOR; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NORADRENALIN; SEROTONIN; SEROTONIN 1A ANTAGONIST; SEROTONIN TRANSPORTER; TRANYLCYPROMINE; VANOXERINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY DISORDER; ARTICLE; BODY TEMPERATURE; BRAIN; CATECHOLAMINE RELEASE; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG EFFECT; FEMALE; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOTHERMIA; MALE; MOUSE; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; SEROTONIN SYNDROME; SEROTONINERGIC SYSTEM; SEX DIFFERENCE; WILD TYPE;

5-HYDROXYTRYPTOPHAN; 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; BRAIN; BRAIN CHEMISTRY; CATECHOLAMINES; CLORGYLINE; DOPAMINE UPTAKE INHIBITORS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; HYDROXYINDOLEACETIC ACID; HYPOTHERMIA; MALE; MICE; MICE, KNOCKOUT; MONOAMINE OXIDASE INHIBITORS; PHENOLS; PIPERAZINES; PYRIDINES; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN SYNDROME; SULFONAMIDES; TRANYLCYPROMINE;

EID: 56349119282     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-008-1268-7     Document Type: Article

References (83)

1. C Alexandre D Popa V Fabre S Bouali P Venault KP Lesch M Hamon J Adrien 2006 Early life blockade of 5-hydroxytryptamine 1A receptors normalizes sleep and depression-like behavior in adult knock-out mice lacking the serotonin transporter J Neurosci 26 5554 5564
2. AM Andrews DL Murphy 1993 Sustained depletion of cortical and hippocampal serotonin and norepinephrine but not striatal dopamine by 1-methyl-4- (2′>-aminophenyl)-1,2,3,6-tetrahydropyridine (2′>-NH2-MPTP): a comparative study with 2′>-CH3-MPTP and MPTP J Neurochem 60 1167 1170
3. MS Ansorge M Zhou A Lira R Hen JA Gingrich 2004 Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice Science 306 879 881
4. MS Ansorge E Morelli JA Gingrich 2008 Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice J Neurosci 28 199 207
5. GB Baker DF LeGatt RT Coutts WG Dewhurst 1984 Rat brain concentrations of 5-hydroxytryptamine following acute and chronic administration of MAO-inhibiting antidepressants Prog Neuro-psychopharmacol Biol Psychiatry 8 653 656
6. Bannon MJ, Sacchetti P, Granneman JG (1998) The dopamine transporter: potential involvement in neuropsychiatric disorders. In: Watson SJ (ed) Psychopharmacology: The fourth generation of progress. Raven Press Ltd., New York, NY., (Available at http://www.acnp.org/G4/toc.htm )
7. D Bengel DL Murphy AM Andrews CH Wichems D Feltner A Heils R Mossner H Westphal KP Lesch 1998 Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("ecstasy") in serotonin transporter-deficient mice Mol Pharmacol 53 649 655
8. DJ Bill M Knight EA Forster A Fletcher 1991 Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia Br J Pharmacol 103 1857 1864
9. RD Blakely HE Berson RT Fremeau Jr. MG Caron MM Peek HK Prince CC Bradley 1991 Cloning and expression of a functional serotonin transporter from rat brain Nature 354 66 70
10. P Bonaventure D Nepomuceno A Kwok W Chai X Langlois R Hen K Stark N Carruthers TW Lovenberg 2002 Reconsideration of 5-hydroxytryptamine (5-HT)(7) receptor distribution using [(3)H]5-carboxamidotryptamine and [(3)H]8-hydroxy-2-(di-n-propylamino)tetraline: analysis in brain of 5-HT(1A) knockout and 5-HT(1A/1B) double-knockout mice J Pharmacol Exp Ther 302 240 248
11. P Bonaventure L Kelly L Aluisio J Shelton B Lord R Galici K Miller TW Lovenberg J Atack C Dugovic 2007 Selective blockade of 5-HT7 receptors enhances 5-HT transmission, antidepressant-like behavior and REM sleep suppression induced by citalopram in rodents J Pharmacol Exp Ther 321 690 698
12. S Bouali A Evrard M Chastanet KP Lesch M Hamon J Adrien 2003 Sex hormone-dependent desensitization of 5-HT1A autoreceptors in knockout mice deficient in the 5-HT transporter Eur J Neurosci 18 2203 12
13. A Caspi K Sugden TE Moffitt A Taylor IW Craig H Harrington J McClay J Mill J Martin A Braithwaite R Poulton 2003 Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene Science 301 386 389
14. V Fabre C Beaufour A Evrard A Rioux N Hanoun KP Lesch DL Murphy L Lanfumey M Hamon MP Martres 2000 Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter Eur J Neurosci 12 2299 2310
15. C Faure O Mnie-Filali H Scarna G Debonnel N Haddjeri 2006 Effects of the 5-HT7 receptor antagonist SB-269970 on rat hormonal and temperature responses to the 5-HT1A/7 receptor agonist 8-OH-DPAT Neurosci Lett 404 122 126
16. M Fox C Jensen P Gallagher D Murphy 2007 Receptor mediation of exaggerated responses to serotonin-enhancing drugs in serotonin transporter (SERT)-deficient mice Neuropharmacology 53 643 656
17. MA Fox AM Andrews JR Wendland KP Lesch A Holmes DL Murphy 2007 A pharmacological analysis of mice with a targeted disruption of the serotonin transporter Psychopharmacology (Berl) 195 147 166
18. G Garcia-Alcocer LC Segura M Garcia Pena A Martinez-Torres R Miledi 2006 Ontogenetic distribution of 5-HT2C, 5-HT5A, and 5-HT7 receptors in the rat hippocampus Gene Expr 13 53 57
19. G Gobbi DL Murphy K Lesch P Blier 2001 Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study J Pharmacol Exp Ther 296 987 995
20. J Gonzalez-Maeso T Yuen BJ Ebersole E Wurmbach A Lira M Zhou N Weisstaub R Hen JA Gingrich SC Sealfon 2003 Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex J Neurosci 23 8836 8843
21. GM Goodwin RJ De Souza AR Green 1985 The pharmacology of the hypothermic response in mice to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). A model of presynaptic 5-HT1 function Neuropharmacology 24 1187 1194
22. GM Goodwin RJ De Souza AJ Wood AR Green 1986 The enhancement by lithium of the 5-HT1A mediated serotonin syndrome produced by 8-OH-DPAT in the rat: evidence for a post-synaptic mechanism Psychopharmacology (Berl) 90 488 493
23. GM Goodwin RJ De Souza AR Green 1987 Attenuation by electroconvulsive shock and antidepressant drugs of the 5-HT1A receptor-mediated hypothermia and serotonin syndrome produced by 8-OH-DPAT in the rat Psychopharmacology (Berl) 91 500 505
24. GM Goodwin RJ De Souza AR Green DJ Heal 1987 The pharmacology of the behavioural and hypothermic responses of rats to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) Psychopharmacology (Berl) 91 506 511
25. MR Guscott E Egan GP Cook JA Stanton MS Beer TW Rosahl S Hartmann J Kulagowski G McAllister KC Fone PH Hutson 2003 The hypothermic effect of 5-CT in mice is mediated through the 5-HT7 receptor Neuropharmacology 44 1031 1037
26. M Guscott LJ Bristow K Hadingham TW Rosahl MS Beer JA Stanton F Bromidge AP Owens I Huscroft J Myers NM Rupniak S Patel PJ Whiting PH Hutson KC Fone SM Biello JJ Kulagowski G McAllister 2005 Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression Neuropharmacology 48 492 502
27. JJ Hagan GW Price P Jeffrey NJ Deeks T Stean D Piper MI Smith N Upton AD Medhurst DN Middlemiss GJ Riley PJ Lovell SM Bromidge DR Thomas 2000 Characterization of SB-269970-A, a selective 5-HT(7) receptor antagonist Br J Pharmacol 130 539 548
28. AR Hariri A Holmes 2006 Genetics of emotional regulation: the role of the serotonin transporter in neural function Trends Cogn Sci 10 182 191
29. PB Hedlund PE Danielson EA Thomas K Slanina MJ Carson JG Sutcliffe 2003 No hypothermic response to serotonin in 5-HT7 receptor knockout mice Proc Natl Acad Sci USA 100 1375 1380
30. PB Hedlund L Kelly C Mazur T Lovenberg JG Sutcliffe P Bonaventure 2004 8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents Eur J Pharmacol 487 125 132
31. PB Hedlund S Huitron-Resendiz SJ Henriksen JG Sutcliffe 2005 5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern Biol Psychiatry 58 831 837
32. WE Heydorn 1999 Paroxetine: a review of its pharmacology, pharmacokinetics and utility in the treatment of a variety of psychiatric disorders Expert Opin Investig Drugs 8 417 441
33. A Holmes RJ Yang DL Murphy JN Crawley 2002 Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter Neuropsychopharmacology 27 914 923
34. A Holmes Q Li DL Murphy E Gold JN Crawley 2003 Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background Genes Brain Behav 2 365 380
35. A Holmes RJ Yang KP Lesch JN Crawley DL Murphy 2003 Mice lacking the serotonin transporter exhibit 5-HT(1A) receptor-mediated abnormalities in tests for anxiety-like behavior Neuropsychopharmacology 28 2077 2088
36. D Hoyer DE Clarke JR Fozard PR Hartig GR Martin EJ Mylecharane PR Saxena PP Humphrey 1994 International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin) Pharmacol Rev 46 157 203
37. XZ Hu RH Lipsky G Zhu LA Akhtar J Taubman BD Greenberg K Xu PD Arnold MA Richter JL Kennedy DL Murphy D Goldman 2006 Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder Am J Hum Genet 78 815 826
38. T Izumi N Iwamoto Y Kitaichi A Kato T Inoue T Koyama 2006 Effects of co-administration of a selective serotonin reuptake inhibitor and monoamine oxidase inhibitors on 5-HT-related behavior in rats Eur J Pharmacol 532 258 264
39. BL Jacobs 1976 An animal behavior model for studying central serotonergic synapses Life Sci 19 777 785
40. BJ Jones TP Blackburn 2002 The medical benefit of 5-HT research Pharmacol Biochem Behav 71 555 568
41. AV Kalueff MA Fox PS Gallagher DL Murphy 2007 Hypolocomotion, anxiety and serotonin syndrome-like behavior contribute to the complex phenotype of serotonin transporter knockout mice Genes Brain Behav 6 389 400
42. GA Kennett SL Dickinson G Curzon 1985 Central serotonergic responses and behavioural adaptation to repeated immobilisation: the effect of the corticosterone synthesis inhibitor metyrapone Eur J Pharmacol 119 143 152
43. DK Kim TJ Tolliver SJ Huang BJ Martin AM Andrews C Wichems A Holmes KP Lesch DL Murphy 2005 Altered serotonin synthesis, turnover and dynamic regulation in multiple brain regions of mice lacking the serotonin transporter Neuropharmacology 49 798 810
44. KP Lesch D Bengel A Heils SZ Sabol BD Greenberg S Petri J Benjamin CR Muller DH Hamer DL Murphy 1996 Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region Science 274 1527 1531
45. Q Li C Wichems A Heils LD Van De Kar KP Lesch DL Murphy 1999 Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice J Pharmacol Exp Ther 291 999 1007
46. Q Li C Wichems A Heils KP Lesch DL Murphy 2000 Reduction in the density and expression, but not G-protein coupling, of serotonin receptors (5-HT1A) in 5-HT transporter knock-out mice: gender and brain region differences J Neurosci 20 7888 7895
47. I Lucki MS Nobler A Frazer 1984 Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat J Pharmacol Exp Ther 228 133 139
48. KF Martin I Phillips M Hearson MR Prow DJ Heal 1992 Characterization of 8-OH-DPAT-induced hypothermia in mice as a 5-HT1A autoreceptor response and its evaluation as a model to selectively identify antidepressants Br J Pharmacol 107 15 21
49. TA Mathews DE Fedele FM Coppelli AM Avila DL Murphy AM Andrews 2004 Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression J Neurosci Methods 140 169 181
50. RH McKim DG Calverly WG Dewhurst GB Baker 1983 Regional concentrations of cerebral amines: effects of tranylcypromine and phenelzine Prog Neuro-psychopharmacol Biol Psychiatry 7 783 786
51. S Montanez WA Owens GG Gould DL Murphy LC Daws 2003 Exaggerated effect of fluvoxamine in heterozygote serotonin transporter knockout mice J Neurochem 86 210 219
52. R Mossner R Simantov A Marx KP Lesch I Seif 2006 Aberrant accumulation of serotonin in dopaminergic neurons Neurosci Lett 401 49 54
53. PR Moya KA Berg MA Gutierrez-Hernandez P Saez-Briones M Reyes-Parada BK Cassels WP Clarke 2007 Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors J Pharmacol Exp Ther 321 1054 1061
54. DL Murphy KP Lesch 2008 Targeting the murine serotonin transporter: insights into human neurobiology Nat Rev Neurosci 9 85 96
55. DL Murphy AM Andrews CH Wichems Q Li M Tohda B Greenberg 1998 Brain serotonin neurotransmission: an overview and update with an emphasis on serotonin subsystem heterogeneity, multiple receptors, interactions with other neurotransmitter systems, and consequent implications for understanding the actions of serotonergic drugs J Clin Psychiatry 59 Suppl 15 4 12
56. DL Murphy A Lerner G Rudnick KP Lesch 2004 Serotonin transporter: gene, genetic disorders, and pharmacogenetics Mol Interv 4 109 123
57. MJ Owens CB Nemeroff 1998 The serotonin transporter and depression Depress Anxiety 8 Suppl 1 5 12
58. Y Pan E Gembom W Peng KP Lesch R Mossner R Simantov 2001 Plasticity in serotonin uptake in primary neuronal cultures of serotonin transporter knockout mice Brain Res Dev Brain Res 126 125 129
59. AM Persico E Mengual R Moessner FS Hall RS Revay I Sora J Arellano J DeFelipe JM Gimenez-Amaya M Conciatori R Marino A Baldi S Cabib T Pascucci GR Uhl DL Murphy KP Lesch F Keller 2001 Barrel pattern formation requires serotonin uptake by thalamocortical afferents, and not vesicular monoamine release J Neurosci 21 6862 6873
60. D Popa C Lena C Alexandre J Adrien 2008 Lasting syndrome of depression produced by reduction in serotonin uptake during postnatal development: evidence from sleep, stress, and behavior J Neurosci 28 3546 3554
61. N Praschak-Rieder J Kennedy AA Wilson D Hussey A Boovariwala M Willeit N Ginovart S Tharmalingam M Masellis S Houle JH Meyer 2007 Novel 5-HTTLPR allele associates with higher serotonin transporter binding in putamen: a [(11)C] DASB positron emission tomography study Biol Psychiatry 62 327 331
62. Y Qu N Villacreses DL Murphy SI Rapoport 2005 5-HT2A/2C receptor signaling via phospholipase A2 and arachidonic acid is attenuated in mice lacking the serotonin reuptake transporter Psychopharmacology (Berl) 180 12 20
63. A Ravary A Muzerelle M Darmon DL Murphy R Moessner KP Lesch P Gaspar 2001 Abnormal trafficking and subcellular localization of an N-terminally truncated serotonin transporter protein Eur J Neurosci 13 1349 1362
64. A Schmitt R Mossner A Gossmann IG Fischer V Gorboulev DL Murphy H Koepsell KP Lesch 2003 Organic cation transporter capable of transporting serotonin is up-regulated in serotonin transporter-deficient mice J Neurosci Res 71 701 709
65. A Serretti F Benedetti R Zanardi E Smeraldi 2005 The influence of Serotonin Transporter Promoter Polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments Prog Neuro-psychopharmacol Biol Psychiatry 29 1074 1084
66. T Sharp L Boothman J Raley P Queree 2007 Important messages in the 'post': recent discoveries in 5-HT neurone feedback control Trends Pharmacol Sci 28 629 636
67. HW Shen Y Hagino H Kobayashi K Shinohara-Tanaka K Ikeda H Yamamoto T Yamamoto KP Lesch DL Murphy FS Hall GR Uhl I Sora 2004 Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters Neuropsychopharmacology 29 1790 1799
68. Sheridan D, Wichems C, Murphy D, Andrews A (1999) The effects of PCPA on monoamine neurotransmitter levels in mice with a disruption of the serotonin transporter gene. Proceedings of the 29th Annual Meeting of the Society for Neuroscience
69. LM Smith SJ Peroutka 1986 Differential effects of 5-hydroxytryptamine1a selective drugs on the 5-HT behavioral syndrome Pharmacol Biochem Behav 24 1513 1519
70. I Sora FS Hall AM Andrews M Itokawa XF Li HB Wei C Wichems KP Lesch DL Murphy GR Uhl 2001 Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference Proc Natl Acad Sci USA 98 5300 5305
71. OA Tjurmina I Armando JM Saavedra DS Goldstein DL Murphy 2002 Exaggerated adrenomedullary response to immobilization in mice with targeted disruption of the serotonin transporter gene Endocrinology 143 4520 4526
72. R Uher P McGuffin 2008 The moderation by the serotonin transporter gene of environmental adversity in the aetiology of mental illness: review and methodological analysis Mol Psychiatry 13 131 146
73. ML Vizuete JL Venero E Traiffort C Vargas A Machado J Cano 1997 Expression of 5-HT7 receptor mRNA in rat brain during postnatal development Neurosci Lett 227 53 56
74. CL Wellman A Izquierdo JE Garrett KP Martin J Carroll R Millstein KP Lesch DL Murphy A Holmes 2007 Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice J Neurosci 27 684 691
75. A Wesolowska A Nikiforuk K Stachowicz 2006 Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats Eur J Pharmacol 553 185 190
76. A Wesolowska A Nikiforuk K Stachowicz E Tatarczynska 2006 Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression Neuropharmacology 51 578 586
77. A Wesolowska E Tatarczynska A Nikiforuk E Chojnacka-Wojcik 2007 Enhancement of the anti-immobility action of antidepressants by a selective 5-HT(7) receptor antagonist in the forced swimming test in mice Eur J Pharmacol 555 43 47
78. DL Willins HY Meltzer 1997 Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats J Pharmacol Exp Ther 282 699 706
79. JP Wisor SW Wurts FS Hall KP Lesch DL Murphy GR Uhl DM Edgar 2003 Altered rapid eye movement sleep timing in serotonin transporter knockout mice NeuroReport 14 233 238
80. Y Xu Y Sari FC Zhou 2004 Selective serotonin reuptake inhibitor disrupts organization of thalamocortical somatosensory barrels during development Brain Res Dev Brain Res 150 151 161
81. J Yamada Y Sugimoto K Horisaka 1988 The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice Eur J Pharmacol 154 299 304
82. S Zhao J Edwards J Carroll L Wiedholz RA Millstein C Jaing DL Murphy TH Lanthorn A Holmes 2006 Insertion mutation at the C-terminus of the serotonin transporter disrupts brain serotonin function and emotion-related behaviors in mice Neuroscience 140 321 334
83. FC Zhou KP Lesch DL Murphy 2002 Serotonin uptake into dopamine neurons via dopamine transporters: a compensatory alternative Brain Res 942 109 119